Results

1–10 of 59 results for Subretinal

1-Year Results of a Phase 2 Pharmacodynamic Study: Subretinal Delivery of Investigational Gene Therapy ABBV-RGX-314 for Neovascular AMD
Robert L. Avery, MD
Updates from the Field
2025
Subretinal Pneumatic Displacement Without Tissue Plasminogen Activator for Submacular Hemorrhage: One-year Outcomes
Marwan Abdulaal, MD
Annual Meeting Talks
2022
Interim Subretinal Gene Therapy Safety Results in Two Phase 1/2 Open-label, Dose-Escalation Clinical Trials to Treat Achromatopsia
Lejla Vajzovic, MD, FASRS
Annual Meeting Talks
2022
Transretinal Subretinal Fluid Injection Technique for Refractory or Chronic Large Macular Holes
Gregory D Lee, MD
Annual Meeting Talks
2022
Two-Year Evaluation of Subretinal Fluid Drainage Techniques in Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment (ELLIPSOID-2 Study)
Bryon McKay, MD, PhD, FRCSC
Annual Meeting Talks
2022
Retinal Detachment Repair After Inadvertent Subretinal Injection of Triamcinolone Following an Attempted Sub-Tenon Injection
On Demand Cases, Courses, and Papers
2022
Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa: Phase 2 Randomized Controlled Masked Multicenter Clinical Trial (Skyline) Interim Safety Results
On Demand Cases, Courses, and Papers
2022
Subretinal Fibrosis in Patients With Choroidal Neovascularization Based on Spectral-Domain Optical Coherence Tomography Classification: Findings from the HARBOR Trial
On Demand Cases, Courses, and Papers
2022
Subretinal Hemorrhage
Akansha Sharma
Retina Image Bank: Images of the Week
2023
Outcomes of Subretinal Fluid Drainage Methods in Pars Plana Vitrectomy for Primary Retinal Detachment
Jose J Echegaray, MD
On Demand Cases, Courses, and Papers
2021